Needle pierces flesh, and the Wolverine stack is in.

A UCLA biochemistry student depresses the rubbery plunger of his syringe as the stack – a peptide blend of TB-500 and BPC-157 lauded for its muscle recovery capabilities – floods his bloodstream. His dorm metamorphoses into a site of self-experimentation.

“You are the guinea pig in this situation,” he said. “You’re the rat.”

The student, who requested anonymity because of the potential personal ramifications of disclosing drug use, became interested in peptides after he injured his hip flexor during his first year at UCLA. An avid weightlifter, he was eager to return to the gym and started considering peptides to heal his injury. The student first heard rumblings from the underworld of injectable peptides in late high school and wondered how the substances could assuage his pain.

“You are the guinea pig in this situation,” he said. “You’re the rat.”

A month of minimal improvement to his hip flexor cemented the student’s decision to use peptides. Reflecting on this judgment with painfully clear hindsight, he now wishes he had consulted a medical expert before gambling on underresearched substances. With his vision clouded by the illusion of rapid recovery, the student could not foresee how the Wolverine stack would soon imperil both his mental stability and most cherished relationships.

“When your life revolves around fitness, you get irrational when things fall apart,” he said.

Peptides surged in popularity in 2021 when the Food and Drug Administration approved Wegovy, a GLP-1 – Glucagon-Like Peptide-1 receptor agonist medication, which increases satiety after eating – for weight loss. Although Saxenda, another GLP-1, was greenlit to treat obesity in 2014, GLP-1s did not accumulate widespread acclaim until 2021 because Saxenda’s efficacy was modest compared to Wegovy’s.

Social media subsequently bolstered the slimming substances’ fame, and before long, peptides beyond GLP-1s began infiltrating algorithms. Prominent celebrities including Joe Rogan and Gwyneth Paltrow praised peptides for their supposed regenerative and anti-aging abilities. As synthetic peptides now await potential approval for retail in specialized pharmacies, medical experts worry about the minimal long-term research on the drugs – and their potentially unfavorable side effects.

The first anxiety attack hit while the student was walking to the gym. By this point, he had titrated up – gradually increasing peptide dosage is necessary to gauge adverse reactions – to his full dosage of 500 mg each of BPC-157 and TB-500.

A violent surge of panic arrested the student mid-stroll. His mind replayed the day’s events on an inescapable loop as his chest tightened.

The student said he had never experienced such episodes, which typically lasted for about an hour, prior to injecting the Wolverine stack. He added that the peptides significantly exacerbated the existing anxiety he already experienced.

“I suddenly was breaking down multiple times a week,” he said. “On a regular basis, I’m probably crying two times a month, but it was much, much more frequent during that time.”

For the remaining two weeks during which the student jabbed himself with TB-500 and BPC-157 twice daily, he suffered similar panic attacks.

Deemed the simpler versions of proteins, peptides are short chains of amino acids linked by chemical bonds. The specific amino acid combination dictates a given peptide’s function, which can be positive or negative. Peptides can be produced naturally in the human body or synthesized in a lab – the latter method is commonly employed to prepare injectable peptides, including TB-500 and BPC-157. Unlike organically occurring peptides such as insulin, many synthetic peptides are not FDA-regulated, meaning they lack rigorous clinical testing on humans.

The current lack of federal supervision of synthetic peptides means the quality of the substances is never guaranteed, said Pinchas Cohen, dean of the University of Southern California’s Leonard Davis School of Gerontology.

Cohen discovered the now-celebrated peptide MOTS-c 11 years ago at UCLA, where he served as a professor and vice chair for research at the Mattel Children’s Hospital. Cohen and collaborating scientists determined MOTS-c prompted modest weight loss and improvement in liver function and blood glucose for obese patients with fatty liver.

Cohen is passionate about developing MOTS-c for its muscle-preserving powers in aging patients, but he believes the version of his discovery being sold through unapproved avenues is impure. Cohen said researchers in his laboratory have given him syringes that supposedly contain MOTS-c, only to discover the samples either contain a small fraction of what is advertised, or no MOTS-c at all.

Moreover, although MOTS-c has proven promising for preventing progressive loss of skeletal muscle mass – or sarcopenia – in aging patients, there have been no studies published regarding the peptide’s effects on healthy adolescents, said Cohen. He added that young people are not MOTS-c’s intended audience.

Despite expert concerns, peptides are becoming a cornerstone of online fitness content. Muscled 20-something weightlifting influencers such as Shane Stoffer – who goes by Togi online – and David Laid encourage their viewers to consume peptides to maximize strength.

“If you don’t take MOTS-c, NAD and Semax-Selank, you’re missing out,” Togi said in one YouTube video. “Those are the most epic peptides on the planet.”

With his hip flexor exhibiting zero signs of improvement and his desire to get back in the gym amplifying, the biochemistry student heeded internet advice when weighing whether to try peptides. As he began exploring options for peptide therapy, he consulted a notorious virtual fountain of knowledge: Reddit.

More than 50,000 users weekly frequent the r/peptides forum, where posts span queries such as “Best way to conceal peptides in fridge” and “CJC Ipamorelin injection site very itchy.” The Wolverine Stack is especially esteemed on r/peptides, and the posts follow something of a formula: a Redditor states his injury, rattles off the dosages of TB-500 and BPC-157 he is taking to ameliorate his pain and finally extols the stack’s healing powers.

Reddit’s barrage of success stories was enough for the biochemistry student to shirk medical advice and investigate online synthesis companies – retailers that create custom chemical compounds. These suppliers have risen in popularity post-2021 GLP-1 boom. On this site, one peptide vial, which contains about seven to 10 days worth of supply, sells for anywhere from $40 to several hundred dollars.

After clicking into a peptide purveyor’s website, users face messages insisting that peptides are sold exclusively for laboratory research. A disclaimer on the website Biotech Peptides reads, “The products on this website are only for research professionals of 21+ years of age, purchasing for research purposes only. Any human or animal consumption is strictly prohibited.”

The legal driver behind precautions such as those posted by Biotech Peptides is the Federal Food, Drug and Cosmetic Act, which mandates that any substance intended for human diagnosis, cure, mitigation, or treatment must undergo clinical testing and receive formal FDA approval. Branding peptides exclusively for laboratory use is a loophole used by distributors to sell directly to consumers without needing government approval.

The only action users must take to bypass this safeguard is to check a box confirming they are 21 years of age or older – and that they will not use the peptides for any purpose other than laboratory research. That’s how, with the click of a few buttons, the UCLA student shipped peptides directly to his dorm.

Even so, enthusiastic peptide purchasers may not have to masquerade as researchers for long. In July 2026, the Pharmacy Compounding Advisory Committee – the arm of the FDA that advises the government on drug compounding – recommended six peptides be added to the 503A bulk drug compounding list. Compounding is the process by which a licensed pharmacist alters an existing drug to create a medication tailored to a patient’s specific needs.

If the FDA accepts adding the recommended peptides – BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax – to the 503A list, specialty compounding pharmacies would be legally authorized to manufacture and distribute the substances to patients. In skirting the robust testing and evidence-gathering process required of of FDA-approved substances, these pharmacies endanger consumers by increasing the availability of unapproved drugs, said Aaron Kesselheim, a professor of medicine at Harvard Medical School and a faculty member in pharmacoepidemiology and pharmacoeconomics at Brigham and Women’s Hospital.

“I don’t think there’s any justification for a product to become widely available without being subject to rigorous testing, given how dangerous it could be,” he said.

Kesselheim added that if the FDA confirms the PCAC’s recommendation, peptide regulation could become highly subjective, given the variance in oversight of compounding pharmacies across different states. Camila Strassle, a former FDA attorney, said in an emailed statement that the committee meeting signals government friendliness to the peptide industry and suggests deprioritization of peptides as a subject of enforcement action by the agency.

The FDA will consider the PCAC’s recommendations, consult with the United States Pharmacopeia – a nonprofit that develops public quality standards – and devise a proposed rule regarding the recommended peptides, an FDA spokesperson said in an emailed statement. Strassle added that the PCAC will convene again before the end of February 2027 to review five additional peptides for the list.

The Trump administration’s enthusiasm for peptides is mirrored by longevity physicians – medical degree holders who seek to help people live long lives. Dr. Arvind Chakravarthy, a Los Angeles-based longevity physician and entrepreneur, said he believes peptides enable patients to manipulate cell signaling in pursuit of increased cell and body health, before illnesses crop up.

Through his health and performance platform Dr. Arvind MD, Chakravarthy consults clients on a peptide-positive approach dubbed “Medicine 4.0.” He describes “Medicine 1.0” as survival medicine – WWI-era amputations – “Medicine 2.0” as visiting the hospital when sick and “Medicine 3.0” as routine check-ups. For Chakravarthy, Medicine 4.0 goes beyond preventative care – it optimizes the body by combining emerging artificial intelligence technologies and regenerative therapies.

Peptide therapy facilitates stronger collaboration between cells, Chakravarthy said. However, he added, poorly sourced peptides, such as those from unverified “research” companies, can be detrimental to people’s health. Chakravarthy flagged concerns similar Cohen’s: peptides distributed on third-party websites are often not the real substances.

Cohen said he was initially apprehensive about the vote to recommend peptides to the bulk compounding list, but he realized it is the safer option; he would rather patients access peptides through regulated compounding pharmacies than illegal markets. He added that threats to the sterility and quality of these substances remain much higher if the peptides stay off the list, than if they are added.

Confirming Cohen’s anxieties, the UCLA biochemistry student said he did not know where his peptides were manufactured and found it difficult to trust the entities selling his drugs.

Ultimately, his suspiciously sourced substances detracted energy from vital personal relationships. The student hid his injury from loved ones, unwilling to confront their judgment; even so, those close to him noticed a marked shift in his demeanor. Specifically, the student recalls his partner observing that he was particularly anxious during the weeks he used peptides.

After one month of volatile mental health and no recovery in his hip flexor, the student reached a breaking point. He said his ruling to renounce peptides was influenced by the fact that he could not confirm the intended effects of the substances and thus was unconvinced that the benefits of the drugs outweighed their costs. He quit cold turkey and reassumed his steady state after about a week, noting that minimal information was circulated on how to stop the peptides – only tips for how to start them.

The biochemistry student’s brief and tumultuous rendezvous with peptides sullied his previously positive perception of online fitness content and underscored the value of seeking out medical professionals for injuries. The Wolverine stack, no matter its Reddit acclaim, could not cure the student’s injury in the way that time and reduced physical activity might have.

Though the student retired his needles, peptides won’t be exiting the mainstream anytime soon. Algorithms continue to curate feeds brimming with injectable evangelism, and longevity clinics are multiplying in LA and beyond.

Regardless of the traction peptides continue to accumulate, the UCLA biochemistry student is now vehemently sworn off the drugs.

His recommendation to young athletes considering peptides?

“Just lift regularly,” he said. “Treat your body right, and you will be satisfied with where you end up.”